Sevoflurane at 1 MAC provides optimal myocardial protection during off-pump CABG

Scandinavian Cardiovascular Journal

Volumn 47, Issue 3, 2013, Pages 175-184

  Wang, Jiang ^a   Zheng, Hong ^a   Chen, Chun Ling ^a   Lu, Wei ^a   Zhang, Yong Qiang ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Brain natriuretic peptide; Myocardial protection; Sevoflurane troponin

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; DOPAMINE; SEVOFLURANE; TROPONIN I;

ANESTHESIA INDUCTION; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CORRELATIONAL STUDY; ELECTIVE SURGERY; HEART PROTECTION; HUMAN; OFF PUMP CORONARY SURGERY; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADMINISTRATION, INHALATION; ADULT; AGED; ANALYSIS OF VARIANCE; ANESTHETICS, INHALATION; BIOLOGICAL MARKERS; BLOOD PRESSURE; CARDIOTONIC AGENTS; CHINA; CORONARY ARTERY BYPASS, OFF-PUMP; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART DISEASES; HUMANS; MALE; METHYL ETHERS; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; SURGICAL PROCEDURES, ELECTIVE; TIME FACTORS; TREATMENT OUTCOME; TROPONIN I;

EID: 84878144261     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.3109/14017431.2012.760749     Document Type: Article

References (36)

1. Frabdorf J, De Hert S, Schlack W. Anesthesia and myocardial ischemia/reperfusion injury. Br J Anaeth. 2009;103:89-98.
2. Lucchinetti E, Hofer C, Bestmann L, Hersberger M, Feng J, Zhu M, et al. Gene regulatory control of myocardial energy metabolism predicts postoperative cardiac function in patients undergoing off-pump coronary artery bypass graft surgery. Anesthesiology. 2007;106:444-57.
3. Ceyhan D, Tanriverdi B, Bilir A. Comparison of the effects of sevoflurane and isoflurane on myocardial protection in coronary bypass surgery. Anadolu Kardiyol Derg. 2011; 11:257-62.
4. De Hert SG, Cromheecke S, ten Broecke PW, Mertens E, De Blier IG, Stockman BA, et al. Effects of sevoflurane, desflurane, and propofol on recover of myocardial function after coronary surgery in elderl high-risk patients. Anesthesiology. 2003;99:314-23.
5. De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R, ten Broecke PW, De Blier IG, et al. Choice of primary anesthetic regimen can influence intensive care unit stay after coronary surgery with cardiac bypass. Anesthesiology. 2004; 101:9-20.
6. Piriou V, Mantz J, Goldfarb G, Kitakaze M, Chiari P, Paquin S, et al. Sevoflurane preconditioning at 1 MAC only provides limited protection in patients undergoing coronary artery bypass surgery: A randomized bi-centre trial. Brit J Anaesth. 2007;99:624-31.
7. Zitta K, Meybohm P, Bein B, Ohnesorge H, Steinfath M, Scholz J, et al. Cytoprotective effects of the volatile anesthetic sevoflurane are highly dependent on timing and duration of sevoflurane conditioning: findings from a human, in-vitro hypoxia model. Eur J Pharmacol. 2010;645:39-46.
8. Bignami E, Landoni G, Gerli C, Testa V, Mizzi A, Fano G, et al. Sevoflurane vs. propofol in patients with coronary disease undergoing mitral surgery: A randomised study. Acta Anaesthesiol Scand. 2011;56:482-90.
9. Cromheecke S, Pepermans V, Hendrickx E, Lorsomradee S, Ten Broecke PW, Stockman BA, et al. Cardioprotective properties of sevoflurane in patients undergoing aortic valve replacement with cardiopulmonary bypass. Anesth Analg. 2006;103:289-96.
10. Conzen PF, Fischer S, Deter C, Peter K. Sevoflurane provides greater protection of the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery. Anesthesiology. 2003;99:826-33.
11. Bein B, Renner J, Caliebe D, Scholz J, Paris A, Fraund S, et al. Sevoflurane but not propofol preserves myocardial function during minimally invasive direct coronary artery bypass surgery. Anesth Analg. 2005;100:610-6.
12. Nordenskjöld AM, Ahlström H, Eggers KM, Fröbert O, Jaffe AS, Venge P, et al. Short- and long-Term individual variation in cardiac troponin in patients with stable coronary artery disease. Clin Chem. 2012 Nov 26. [Epub aheCad of print].
13. Røsjø H, Kravdal G, Høiseth AD, Jørgensen M, Badr P, Røysland R, et al. Troponin I measured by a high-sensitivity assay in patients with suspected reversible myocardial ischemia: Data from the Akershus Cardiac Examination (ACE) 1 Study. Clin Chem. 2012;58:1565-73.
14. McQueen MJ, Kavsak PA, Xu L, Shestakovska O, Yusuf S. Predicting myocardial infarction and other serious cardiac outcomes using high-sensitivity cardiac troponin T in a highrisk stable population. Clin Biochem. 2012 Oct 9. [Epub ahead of print].
15. Berendes E, Schmidt C, Van Aken H, Hartlage MG, Rothenburger M, Wirtz S, et al. A-Type and B-Type natriuretic peptides in cardiac surgical procedures. Anesth Analg. 2004;98:11-9.
16. Prabhakar H, Ali Z, Bithal PK, Rath GP, Singh D, Dash HH. Isoflurane and sevoflurane decrease entropy indices more than halothane at equal mac values. J Anesth. 2009;23:154-7.
17. Obal D, Preckel B, Scharbatke H, Müllenheim J, Höterkes F, Thämer V, et al. One MAC of sevoflurane provides protection against reperfusion injury in the rat heart in vivo. Br J Anaesth. 2001;87:905-11.
18. Wiese AJ, Barter LS, Ilkiw JE, Kittleson MD, Pypendop BH. Cardiovascular and respiratory effects of incremental doses of dopamine and phenylephrine in the management of isoflurane- induced hypotension in cats with hypertrophic cardiomyopathy. Am J Vet Res. 2012;73:908-916.
19. Iida H, Ohata H, Iida M, Watanabe Y, Dohi S. Isoflurane and sevoflurane induce vasodilation of cerebral vessels via ATP-sensitive K channel activation. Anesthesiology. 1998;89:954-60.
20. Larach DR, Schuler HG. Direct vasodilation by sevoflurane, isoflurane, and halothane alters coronary flow reserve in the isolated rat heart. Anesthesiology. 1991;75:268-78.
21. Gravel NR, Searle NR, Taillefer J, Carrier M, Roy M, Gagnon L. Comparison of the hemodynamic effects of sevoflurane anesthesia induction and maintenance vs TIVA in CABG surgery. Can J Anaesth. 1999;46:240-6.
22. Yao YT, Li LH. Sevoflurane versus propofol for myocardial protection in patients undergoing coronary artery bypass grafting surgery: A meta-Analysis of randomized controlled trials. Chin Med Sci J. 2009;24:133-41.
23. Yu CH, Beattie WS. The effects of volatile anesthetics on cardiac ischemic complications and mortality in CABG: A meta-Analysis. Can J Anaesth. 2006;53:906-18.
24. Venkatesh BG, Mehta Y, Kumar A, Trehan N. Comparison of sevoflurane and isoflurane in opcab surgery. Ann Card Anaesth. 2007;10:46-50.
25. Gerhardt W, Katus H, Ravkilde J, Hamm C, Jørgensen PJ, Peheim E, et al. S-Troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of S-creatine kinase isoenzyme MB. Clin Chem. 1991;37: 1405-11.
26. van Geene Y, van Swieten HA, Noyez L. Cardiac troponin I levels after cardiac surgery as predictor for in-hospital mortality. Interact Cardiovasc Thorac Surg. 2010;10: 413-6.
27. Hashemzadeh K, Dehdilani M. Postoperative cardiac troponin I is an independent predictor of in-hospital death after coronary artery bypass grafting. J Cardiovasc Surg (Torino). 2009;50:403-9.
28. Amin AP, Mukhopadhyay E, Napan S, Mamtani M, Kelly RF, Kulkarni H. Value of early cardiac troponin I to predict long-Term adverse events after coronary artery bypass graft surgery in patients presenting with acute coronary syndromes. Clin Cardiol. 2009;32:386-92.
29. Tzimas PG, Milionis HJ, Arnaoutoglou HM, Kalantzi KJ, Pappas K, Karfis E, et al. Cardiac troponin I versus creatine kinase-MB in the detection of postoperative cardiac events after coronary artery bypass grafting surgery. J Cardiovasc Surg (Torino). 2008;49:95-101.
30. Fellahi JL, Hedoire F, Le Manach Y, Monier E, Guillou L, Riou B. Determination of the threshold of cardiac troponin I associated with an adverse postoperative outcome after cardiac surgery: A comparative study between coronary artery bypass graft, valve surgery, and combined cardiac surgery. Crit Care. 2007;11:R106.
31. Sudoh T, Maekawa K, Kojima M, Minamino N, Kangawa K, Matsuo H. Cloning and sequence analyhsis encoding a precursor for human brain natriuretic peptide. Biochem Biophys Res Commun. 1989;159:1427-34.
32. LaPointe MC. Molecular regulation of the brain natriuretic peptide gene. Peptides. 2005;26:944-56.
33. Seilhamer JJ, Arfsten A, Miller JA, Lundquist P, Scarborough RM, Lewicki JA, et al. Human and canine gene homologs of porcine brain natriuretic peptide. Biochem Biophys Res Commun. 1989;165:650-8.
34. GN, Nicholls DP, Patterson A, Beringer T. Neuropeptide secretion in exercise. Neuropeptides. 1998; 32:319-25.
35. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, et al. Localization and mechanism of secretion of B-Type natriuretic peptide in comparison with those of A-Type natriuretic peptide in normal subjects and patients with heart failure. Circulation. 1994;90:195-203.
36. Bruneau BG, de Bold AJ. Selective changes in natriuretic peptide and early response gene expression in isolated rat atria following stimulation by stretch or endothelin-1. Cardiovasc Res. 1994;28:1519-25.